학술논문

Efficacy, Safety, Patient Experience, and Tolerability of Risankizumab Administered by On-Body Injector for Moderate to Severe Crohn’s Disease
Document Type
Article
Source
In: Advances in Therapy. (Advances in Therapy, May 2023, 40(5):2311-2325)
Subject
Language
English
ISSN
18658652
0741238X